![Pyrazoles and Pyrrolo[3,2-c]pyridines as Anticancer Agents - El-Gamal, Mohammed I.;Oh, Chang-Hyun](https://bilder.buecher.de/produkte/36/36403/36403899z.jpg "Pyrazoles and Pyrrolo[3,2-c]pyridines as Anticancer Agents - El-Gamal, Mohammed I.;Oh, Chang-Hyun")
Andere Kunden interessierten sich auch für
![Sulfonated Derivatives of 2,4-Xylidine: Possible Therapeutic Agents]( "Sulfonated Derivatives of 2,4-Xylidine: Possible Therapeutic Agents")
Sulfonated Derivatives of 2,4-Xylidine: Possible Therapeutic Agents26,99 €![Synthesis of Thymidine Analogues as Antimicrobial & Anticancer Agents]( "Synthesis of Thymidine Analogues as Antimicrobial & Anticancer Agents")
Synthesis of Thymidine Analogues as Antimicrobial & Anticancer Agents40,99 €![Computer-aided molecular design to discovery potent anticancer agents]( "Computer-aided molecular design to discovery potent anticancer agents")
Computer-aided molecular design to discovery potent anticancer agents26,99 €![Photoactivated Metallopharmaceuticals as Anticancer Agents]( "Photoactivated Metallopharmaceuticals as Anticancer Agents")
Photoactivated Metallopharmaceuticals as Anticancer Agents39,99 €![5-Aryl 1,3,4 -Thiadiazole Derivatives As Potential Anticancer Agents]( "5-Aryl 1,3,4 -Thiadiazole Derivatives As Potential Anticancer Agents")
5-Aryl 1,3,4 -Thiadiazole Derivatives As Potential Anticancer Agents36,99 €![Kinetics of Condensation Reactions for Bioactive Molecules]( "Kinetics of Condensation Reactions for Bioactive Molecules")
Kinetics of Condensation Reactions for Bioactive Molecules42,99 €![Synthesis of N-aryl Pyrazoles via Chan-Lam Coupling]( "Synthesis of N-aryl Pyrazoles via Chan-Lam Coupling")
Synthesis of N-aryl Pyrazoles via Chan-Lam Coupling36,99 €
In the present investigation, novel pyrazoles and pyrrolo[3,2-c]pyridines have been designed as potential antiproliferative agents against different types of cancer. Their antiproliferative activities were examined against 61 cancer cell lines of 9 different cancer types. Biological investigation of representative target compounds at molecular level was conducted in order to investigate the possible mechanism(s) of antiproliferative activity of our target compounds. In addition, molecular modeling study was carried out. Some compounds showed broad-spectrum antiproliferative activity, while others demonstrated selectivity over certain types of cancer. Our research led to discovery a selective FMS kinase inhibitor, multiple-kinase inhibitor, ERK kinase inhibitors, and dual ERK/COX-2 inhibitors. This work led to development of novel lead anticancer agents, which can be utilized for future development of potential anticancer agents.